[Lipid peroxidation, cardiovascular risk factors and statin]

Med Clin (Barc). 2011 Feb 26;136(5):202-4. doi: 10.1016/j.medcli.2010.09.017. Epub 2010 Dec 8.
[Article in Spanish]
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Atherosclerosis / etiology
  • Atherosclerosis / immunology
  • Atherosclerosis / metabolism
  • Atherosclerosis / prevention & control
  • Biomarkers
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / immunology
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / immunology
  • Hypercholesterolemia / metabolism
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Inflammation
  • Lipid Peroxidation / drug effects*
  • Lipoproteins, LDL / immunology
  • Lipoproteins, LDL / metabolism
  • Male
  • Malondialdehyde / blood
  • Risk Factors

Substances

  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunoglobulin G
  • Immunoglobulin M
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Malondialdehyde